Pharmacological dose of α-tocopherol induces cardiotoxicity in Wistar rats determined by echocardiography and histology

Human and Experimental Toxicology

Volumn 30, Issue 10, 2011, Pages 1540-1548

  Nascimento, Maria Carolina Mo ^a   Matsubara, Beatriz B ^a   Matsubara, Luiz S ^a   Correa, Camila R ^a   Pereira, Elenize J ^a   Moreira, Priscila L ^a   Carvalho, Flavio A ^a   Burini, Caio H ^a   Padovani, Carlos R ^a   Yeum, Kyung Jin ^b   Ferreira, Ana Lucia A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b TUFTS UNIVERSITY   (United States)

Author keywords

tocopherol; cardiotoxicity; Doppler echocardiogram; rat

Indexed keywords

ALPHA TOCOPHEROL; CORN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TISSUE LEVEL; DRUG UPTAKE; ECHOCARDIOGRAPHY; FEEDING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART MUSCLE CELL; HEART WEIGHT; HISTOLOGY; HYPERVITAMINOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-TOCOPHEROL; ANIMALS; ECHOCARDIOGRAPHY, DOPPLER; HEART; MALE; MYOCARDIUM; RATS; RATS, WISTAR; WEIGHT LOSS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 80054860516     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110392401     Document Type: Article

References (33)

1. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WCV. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993 ; 328: 1444-1449 (Pubitemid 23143846)
2. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996 ; 334: 1156-1162 (Pubitemid 26137974)
3. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993 ; 328: 1450-1456 (Pubitemid 23143847)
4. 2++ ATPase downregulation after myocardial infarction. Free Radic Biol Med. 2006 ; 40: 1827-1842
5. The HOPE, Trial Investigators HOPE-TOO. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 ; 293: 1338-1347
6. Breed JG, Zimmerman AN, Dormans JA, Pinedo HM. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit. Cancer Res. 1980 ; 40: 2033-2038 (Pubitemid 10116133)
7. Van Vleet JF, Ferrans VJ, Weirich WE. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. Am J Pathol. 1980 ; 99: 13-42
8. Miller ERr, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: Highdosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005 ; 142 (142). 137-146
9. Marchioli R, Levantesi G, Macchia A, Marfisi R, Nicolosi G, Tavazzi L, et al. Vitamin E increases the risk of developing heart failure after myocardial infarction: results from de GISSI-Prevenzione trial. J Cardiovasc Med. 2006 ; 7: 347-350 (Pubitemid 44145638)
10. Rietjens IMCM, Boersma MG, de Haan L, Spenkelink B, Awad HM, Cnubben NHP, et al. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Phar. 2002 ; 11: 321-333 (Pubitemid 34694012)
11. Yeum K-J, Ferland G, Patry J, Russell RM. Relationship of plasma carotenoids, retinol and tocopherols in mothers and newborn infants. J Am Coll Nutr. 1998 ; 17: 442-447 (Pubitemid 28445333)
12. Ferreira ALA, Yeum K-J, Matsubara LS, Matsubara BB, Correa CR, Pereira EJ, et al. Doxorubicin as an antioxidant: maintenance of myocardial levels of lycopene under doxorubicin treatment. Free Radic Biol Med. 2007 ; 43: 740-751 (Pubitemid 47102120)
13. Ferreira ALA, Russell RM, Rocha N, Ladeira MSP, Salvadori DMS, Nascimento MCMO, et al. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological, and morphometrical assessment. Basic Clin Pharmacol Toxicol. 2007 ; 101: 16-24 (Pubitemid 46934646)
14. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 ; 58: 1072-1083
15. Billingham ME, Mason JW, Bristow MR, Daniels JR. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978 ; 62: 865-872 (Pubitemid 8377880)
16. Wahab MHA, Akoul EEMS, Abdelaziz AH. Modulatory effects of melatonin and vitamin-E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma bearing mice. Tumori. 2000 ; 86: 157-162
17. Giakoustidis D, Papageorgiou G, Iliadis S, Kontos N, Kostopoulou E, Papachrestou A, et al. Intramuscular administration of very high dose of α-tocopherol protects liver from severe ischemia-reperfusion injury. World J Surg. 2002 ; 26: 872-877 (Pubitemid 36920332)
18. Yang NYJ, Desai ID. Effect of high levels of dietary vitamin E on hematological indices and biochemical parameters in rats. J Nutr. 1977 ; 107: 1410-1417 (Pubitemid 8167076)
19. Danelisen I, Palace V, Lou H, Singal PK. Maintenance of myocardial levels of vitamin A in heart failure due to adriamycin. J Mol Cell Cardiol. 2002 ; 34: 789-795 (Pubitemid 35205181)
20. Legha SS, Wang YM, Mackay B, Ewer M, Hortobagyi GN, Benjamin RS, Ali MK. Clinical and pharmacologic investigation of the effects of α-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci. 1982 ; 393: 411-418 (Pubitemid 13206927)
21. Demole V. Pharmakologisches uber vitamin E. Int Z Vitaminforsch. 1939 ; 8: 338-341
22. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation (TMP) of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 1999 ; 13: 977-994 (Pubitemid 29249724)
23. Stocker R. The ambivalence of vitamin E in atherogenesis. TIBS. 1999 ; 24: 219
24. Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med. 1997 ; 22: 57-71 (Pubitemid 26399311)
25. Bowry VW, Stocker R.. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc Society. 1993 ; 115: 6029-6044 (Pubitemid 23278118)
26. Witting PK, Westerlund C, Stocker R. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J Lipid Res. 1996 ; 37: 853-867
27. Upston JM, Terentis AC, Morris K, Keaney JFJ, Stocker R. Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis. Biochem J. 2002 ; 363: 753-760 (Pubitemid 34526396)
28. Keaney JF, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, et al. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 1994 ; 93: 844-851
29. Schulte I, Bektas H, Klempnauer J, Borlak J. Vitamin E in heart transplantation: effects on cardiac gene expression. Transplantation. 2006 ; 81: 736-745
30. Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamine E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr. 1997 ; 65: 496-502 (Pubitemid 27130758)
31. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994 ; 330: 1029-1035
32. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr. 1988 ; 48: 612-619
33. Meydani SN, Barklund PM, Liu S, Meydani M, Miller R, Cannon J, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr. 1990 ; 52: 557-563